Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Interleukin Genetics Inc (ILI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Interleukin Genetics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1037649.
Total stock buying since 2014: $55,925,460.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2016 | 276,986,914 | $27,421,692 | 0 | $0 | 0 | $0 |
| 2014 | 285,037,749 | $28,503,768 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2016-07 | 276,986,914 | $27,421,692 | 0 | $0 | 0 | $0 |
| 2014-12 | 285,037,749 | $28,503,768 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-07-29 | Florence Anthony A. Jr. (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Sonsini Peter W. (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | New Enterprise Associates 14, L.p. (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Viswanathan Ravi (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Bay City Capital Management V Llc (10% Owner) | Buy | 30,181,086 | .10 | 2,987,927 |
| 2016-07-29 | Dipalma Stephen J. (Interim CFO) | Buy | 100,603 | .10 | 9,959 |
| 2016-07-29 | Weller Harry R (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Carbeau Mark B (Chief Executive Officer) | Buy | 100,603 | .10 | 9,959 |
| 2016-07-29 | Baskett Forest (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Kolluri Krishna Kittu (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Weaver James M | Buy | 100,603 | .10 | 9,959 |
| 2016-07-29 | Sandell Scott D (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Kornman Kenneth S (President and CSO) | Buy | 25,150 | .10 | 2,489 |
| 2016-07-29 | Kerins Patrick J (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Mott David M (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Barrett M James (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Barris Peter J (10% Owner) | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-29 | Alticor Inc (10% Owner) | Buy | 5,030,181 | .10 | 497,987 |
| 2014-12-23 | Florence Anthony A. Jr. (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Sonsini Peter W. (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | New Enterprise Associates 14, L.p. (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Viswanathan Ravi (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Bay City Capital Management V Llc (10% Owner) | Buy | 26,491,952 | .10 | 2,649,195 |
| 2014-12-23 | Dipalma Stephen J. (Interim CFO) | Buy | 249,252 | .10 | 24,925 |
| 2014-12-23 | Weller Harry R (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Drant Ryan D (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Baskett Forest (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Kolluri Krishna Kittu (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Sandell Scott D (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Kerins Patrick J (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Mott David M (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Barrett M James (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-23 | Barris Peter J (10% Owner) | Buy | 19,868,965 | .10 | 1,986,896 |
Insider trading activities including stock purchases, stock sales, and option exercises of ILI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Interleukin Genetics Inc (symbol ILI, CIK number 1037649) see the Securities and Exchange Commission (SEC) website.